# Pilot Study to Evaluate the CereVasc® EShunt® System in the Treatment of Communicating Hydrocephalus

> **NCT05501002** · NA · TERMINATED · sponsor: **CereVasc Inc** · enrollment: 4 (actual)

## Conditions studied

- Hydrocephalus
- Hydrocephalus, Communicating

## Interventions

- **DEVICE:** eShunt® Implant

## Key facts

- **NCT ID:** NCT05501002
- **Lead sponsor:** CereVasc Inc
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-09-15
- **Primary completion:** 2023-09-15
- **Final completion:** 2023-09-15
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Low enrollment
- **Last updated:** 2024-11-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05501002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05501002, "Pilot Study to Evaluate the CereVasc® EShunt® System in the Treatment of Communicating Hydrocephalus". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05501002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*